← Every company
Praxis Precision Medicines Inc Patents
What Praxis Precision Medicines Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
PRAX on carbonthat →Filings on file
50
Granted
2
Still pending
48
Filed under
2 names
50 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| KCNT1 INHIBITORS AND METHODS OF USEC07D 413/12, C07D 413/14, A61P 21/00, A61P 9/00, A61P 25/04, A61P 25/00, A61P 25/08, A61P 25/06, A61K 31/16, A61K 31/415, A61K 31/4245, A61K 31/4439, A61K 31/506, C07D 271/06, C07D 413/04Filed as PRAXIS PRECISION MEDICINES, INC.2026-04-29GABRIEL MARTINEZ BOTELLA | pending |
| METHODS OF TREATING ESSENTIAL TREMORA61P 25/14, A61K 31/445, A61P 25/08Filed as Praxis Precision Medicines, Inc.2026-03-06Monique Giroux | pending |
| HIGH STRENGTH SINGLE UNIT DOSE FORMULATIONS AND METHODS OF USE THEREOFA61K 9/2054, A61K 31/445, A61P 21/00, A61K 9/2009, A61K 9/2018, A61K 9/2027, A61K 9/2813, A61K 9/284, A61K 9/2853Filed as Praxis Precision Medicines, Inc.2026-02-13Ahmad Hashash | pending |
| KCNT1 INHIBITORS AND METHODS OF USEC07D 413/04, C07D 413/14, A61P 21/00, A61P 9/06, A61P 25/22, A61P 25/04, A61P 25/18, A61P 25/24, A61P 9/04, A61P 25/00, A61P 25/08, A61P 25/06, A61K 31/4245, A61K 31/427, A61K 31/437, A61K 31/4427, A61K 31/4439, A61K 31/444, A61K 31/4545, A61K 31/501, A61K 31/538, C07D 413/12, C07D 417/12, C07D 417/14, C07D 471/04Filed as Praxis Precision Medicines, Inc.2026-02-10Andrew Mark GRIFFIN | pending |
| FORMULATIONS OF ION CHANNEL MODULATORS AND METHODS OF PREPARATION AND USE OF ION CHANNEL MODULATORSA61K 9/48, C07D 487/04, A61P 25/00, A61P 25/08, A61P 25/06, A61P 35/00, A61K 9/08, A61K 9/10, A61K 9/14, A61K 9/4866, A61K 31/4985, C07B2200/13Filed as Praxis Precision Medicines, Inc.2026-01-13Gabriel Martinez Botella | pending |
| KCNT1 INHIBITORS AND METHODS OF USEC07D 413/14, A61P 25/14, A61P 9/00, A61P 9/06, A61P 25/22, A61P 25/18, A61P 25/24, A61P 25/00, A61P 25/08, A61P 29/00, A61K 31/4439, C07B 59/002Filed as Praxis Precision Medicines, Inc.2025-10-17James Thomas REUBERSON | pending |
| METHODS OF TREATING ESSENTIAL TREMORFiled as PRAXIS PRECISION MEDICINES, INC.2025-10-16MONIQUE GIROUX | pending |
| HIGH STRENGTH SINGLE UNIT DOSE FORMULATIONS AND METHODS OF USE THEREOFA61K 9/2054, A61K 31/445, A61P 21/00, A61K 9/2009, A61K 9/2018, A61K 9/2027, A61K 9/2813, A61K 9/284, A61K 9/2853Filed as Praxis Precision Medicines, Inc.2025-08-27Ahmad Hashash | pending |
| CRYSTALLINE SALT FORMS OF N-((1-(2-(TERT-BUTYLAMINO)-2-OXOETHYL)PIPERIDIN-4-YL) METHYL)-3-CHLORO-5-FLUOROBENZAMIDE AND METHODS OF USE THEREOFA61P 25/00, C07D 211/26, A61K 31/445, C07B2200/13, C07C 55/07, C07C 55/08, C07C 55/12, C07C 55/14, C07C 55/20, C07C 57/145, C07C 57/15, C07C 65/11, C07C 307/02, C07C 309/04, C07C 309/05, C07C 309/29, C07C 309/35, C07D 239/557Filed as Praxis Precision Medicines, Inc.2025-08-27David T. Jonaitis | pending |
| CRYSTALLINE SALTS OF A T-TYPE CALCIUM CHANNEL MODULATOR AND METHODS OF USE THEREOFA61P 25/00, C07D 211/26, A61P 25/16, A61K 9/2054, A61K 31/445, A61K 47/38Filed as Praxis Precision Medicines, Inc.2025-08-27Daniel Thomas Walters | pending |
| METHODS OF TREATING ESSENTIAL TREMORA61K 31/445, A61P 25/14Filed as Praxis Precision Medicines, Inc.2025-08-27Gabriel Maurice Belfort | pending |
| METHODS OF TREATING ESSENTIAL TREMORFiled as Praxis Precision Medicines, Inc.2025-06-16Monique Giroux | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as PRAXIS PRECISION MEDICINES, INC.2025-06-06STEVEN PETROU | pending |
| KCNT1 INHIBITORS COMPRISING A PHENYL, PYRIDINE, OR PYRIMIDINE CORE AND METHODS OF USEA61K 31/444, C07D 401/14, A61P 9/06, A61P 25/22, A61P 25/04, A61P 25/24, A61P 25/00, A61P 25/08, A61K 31/44, A61K 31/506, C07C 311/14, C07C 311/16, C07D 209/08, C07D 213/81, C07D 213/82, C07D 231/56, C07D 249/06, C07D 401/04, C07D 471/04Filed as PRAXIS PRECISION MEDICINES, INC.2025-06-04RICARDO LIRA | pending |
| ION CHANNEL MODULATORSC07D 487/04Filed as Praxis Precision Medicines, Inc.2025-05-30Andrew Mark Griffin | pending |
| ION CHANNEL MODULATORSA61K 45/06, C07D 471/04, C07D 487/04, A61P 25/04, A61P 23/00, A61P 25/18, A61P 25/00, A61P 25/08, A61P 29/00, A61K 31/444, A61K 31/4985, A61K 31/5025, C07B2200/07, C07B2200/13Filed as Praxis Precision Medicines, Inc.2025-05-08Andrew Mark Griffin | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2025-05-02Steven Petrou | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2025-03-31Steven Petrou | pending |
| METHODS OF TREATING ESSENTIAL TREMORFiled as Praxis Precision Medicines, Inc.2025-03-31Monique Giroux | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as PRAXIS PRECISION MEDICINES, INC.2025-03-26KARL HANSEN | pending |
| METHODS OF TREATING PARKINSON'S DISEASE WITH T-TYPE CALCIUM CHANNEL MODULATORSFiled as PRAXIS PRECISION MEDICINES, INC.2025-03-03GABRIEL MAURICE BELFORT | pending |
| DYNAMIC CLAMPS AND METHODS OF USE THEREOFA61P 25/08, G01N 33/48728, A61K 31/658, A61K 31/19, A61K 31/195, A61K 31/197, A61K 31/4166, A61K 31/515, A61K 31/53, A61K 31/55, A61K 31/551, A61K 31/7048, C07K 14/705, G01N2333/705Filed as Praxis Precision Medicines, Inc.2025-02-28Steven Petrou | pending |
| METHODS OF TREATING PARKINSON'S DISEASE WITH T TYPE CALCIUM CHANNEL MODULATORSFiled as Praxis Precision Medicines, Inc.2025-02-21Gabriel Maurice Belfort | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2025-01-22Steven Petrou | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2025-01-10Steven Petrou | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2024-12-18Steven Petrou | pending |
| COMPOUNDS AND THEIR METHODS OF USEA61K 45/06, C07D 487/04, A61P 25/18, A61P 25/00, A61P 25/08, A61K 31/4985, A61K 31/5025Filed as Praxis Precision Medicines, Inc.2024-12-06Kiran Reddy | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2024-11-27Steven Petrou | pending |
| METHODS OF USE OF T-TYPE CALCIUM CHANNEL MODULATORSA61K 9/4858, A61K 31/445, A61P 25/14, A61P 25/08, A61K 9/2054, A61K 9/4866Filed as Praxis Precision Medicines, Inc.2024-11-08Kiran Reddy | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2024-11-06Steven Petrou | pending |
| METHODS OF TREATING ESSENTIAL TREMORFiled as Praxis Precision Medicines, Inc.2024-11-06Monique Giroux | pending |
| TREATMENT OF NEUROLOGICAL DISORDERSA61K 31/444, A61P 25/00, A61P 25/08Filed as Praxis Precision Medicines, Inc.2024-10-25Michael Kristopher Mathieu Kahlig | pending |
| TREATMENT OF NEUROLOGICAL DISORDERSA61K 31/444, A61P 25/00, A61P 25/08Filed as Praxis Precision Medicines, Inc.2024-10-25Michael Kristopher Mathieu Kahlig | pending |
| TREATMENT OF NEUROLOGICAL DISORDERSA61K 31/4985, A61P 25/00, A61P 25/08Filed as Praxis Precision Medicines, Inc.2024-10-25Michael Kristopher Mathieu Kahlig | pending |
| 3-(ETHOXYDIFLUOROMETHYL)-6-(5-FLUORO-6-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-3-YL)-[1,2,4]TRIAZOLO[4,3-a]PYRAZINE AS AN ION CHANNEL MODULATORA61K 31/4985, A61P 25/00, A61P 25/08Filed as Praxis Precision Medicines, Inc.2024-10-25Michael Kristopher Mathieu Kahlig | 12582652 |
| KCNT1 INHIBITORS COMPRISING A PYRAZOLE CORE AND METHODS OF USEC07D 401/14, A61P 25/00, A61K 31/4155, A61K 31/4439, A61K 31/454, A61K 31/506, C07D 231/14, C07D 231/16, C07D 231/18, C07D 231/20, C07D 401/04, C07D 403/12, C07D 403/14, C07D 405/14Filed as PRAXIS PRECISION MEDICINES, INC.2024-10-24Andrew Mark GRIFFIN | pending |
| METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERSA61P 25/00, A61K 31/58, A61P 25/08, A61K 31/437, A61K 31/444, A61K 31/4985, A61K 45/06, A61K2300/00Filed as Praxis Precision Medicines, Inc.2024-10-24STEVEN PETROU | pending |
| ION CHANNEL MODULATORSC07D 487/04, A61P 25/00Filed as Praxis Precision Medicines, Inc.2024-10-16Kiran Reddy | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2024-10-16Karl Hansen | pending |
| METHODS OF TREATING ESSENTIAL TREMORFiled as Praxis Precision Medicines, Inc.2024-10-16Monique Giroux | pending |
| T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A PIPERAZINE OR 1,4-DIAZEPANE CORE AND METHODS OF USE THEREOFA61K 31/4995, C07D 231/12, A61P 25/14, A61P 25/00, A61P 25/08, A61K 31/496, A61K 31/499, A61K 31/5375, C07D 231/56, C07D 233/64, C07D 235/14, C07D 241/04, C07D 241/08, C07D 247/00, C07D 249/08, C07D 261/20, C07D 265/30, C07D 295/15, C07D 401/12, C07D 403/12, C07D 405/06, C07D 405/08, C07D 405/12, C07D 471/04, C07D 471/08, C07D 487/08, C07D 491/107, C07D 498/08Filed as Praxis Precision Medicines, Inc.2024-09-30Ricardo Lira | pending |
| T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING AN AZASPIROHEPTANE CORE AND METHODS OF USE THEREOFA61K 31/403, C07D 205/12, A61P 25/14, A61K 31/4025, A61K 31/4155, A61K 31/4184, A61K 31/422, A61K 31/4409, A61K 31/4725, A61K 31/506, A61K 31/5377, C07D 401/06, C07D 401/12, C07D 401/14, C07D 403/06, C07D 403/12, C07D 405/06, C07D 405/12, C07D 413/06, C07D 413/12, C07D 417/12Filed as Praxis Precision Medicines, Inc.2024-09-30Ricardo Lira | pending |
| T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A DIAZASPIROHEPTANE CORE AND METHODS OF USE THEREOFC07D 487/10, A61P 25/14, A61K 31/397, A61K 31/4184Filed as Praxis Precision Medicines, Inc.2024-09-27Ricardo Lira | pending |
| T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING AN AZASPIRONONANE CORE AND METHODS OF USE THEREOFC07D 205/12, A61P 25/14, A61P 25/00, A61P 25/08, A61K 31/397, A61K 31/4025, A61K 31/4155, A61K 31/4178, A61K 31/422, A61K 31/5377, A61K 31/5386, C07D 403/06, C07D 403/12, C07D 405/06, C07D 405/12, C07D 413/06, C07D 413/12Filed as Praxis Precision Medicines, Inc.2024-09-27Ricardo Lira | pending |
| METHODS OF USING OLIGOMERIC COMPOUNDS TO TREAT SCN2A-RELATED DISORDERSC12N 15/1138, A61P 25/28, A61P 25/08, A61K 31/712, C12N 15/113, C12N2310/11, C12N2310/315, C12N2310/321, C12N2310/3231, C12N2310/3341, C12N2310/341, C12N2320/35, C12N2310/3525Filed as Praxis Precision Medicines, Inc.2024-09-26Michael S. Oldham | pending |
| METHOD OF TREATMENT OF SCN2A-RELATED DISORDERSFiled as PRAXIS PRECISION MEDICINES, INC.2024-09-13WILLIAM MOTEL | pending |
| METHODS OF TREATMENT OF SCN2A-RELATED DISORDERSA61P 25/08, A61K 31/7125, C12N 15/1138, C12N2310/11, C12N2310/315, C12N2310/321, C12N2310/3341, C12N2310/341, C12N2310/3525, C12N2320/34, C12N2320/35Filed as Praxis Precision Medicines, Inc.2024-09-13William Motel | 12618072 |
| DETERMINING EFFECT OF A DRUG BASED ON BRAIN ACTIVITY AND A TRAINED MACHINE LEARNING MODELFiled as PRAXIS PRECISION MEDICINES, INC.2024-09-13AMULYA GARIMELLA | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2024-09-03Steven Petrou | pending |
| METHODS OF TREATMENT OF NEUROLOGICAL DISORDERSFiled as Praxis Precision Medicines, Inc.2024-08-30Steven Petrou | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on PRAX
Company overviewEverything on PRAX in one place, with the price.SEC filingsWhat PRAX's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat PRAX's own officers and directors buy and sell.Executive payWhat PRAX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in PRAX.Funds holding itWhich funds and ETFs hold PRAX, and how big a bet.LobbyingWhat PRAX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on PRAX's account, and who they worked for.